Cerebrolysin
Research PeptideAlso known as: FPE 1070
What is Cerebrolysin?
Cerebrolysin is a porcine brain-derived peptide preparation approved in many countries for stroke, dementia, and traumatic brain injury.
How It Works
Cerebrolysin contains neurotrophic factors that mimic BDNF and NGF activity, promoting neuroplasticity and neuroprotection.
What Research Shows
Key Findings:
- Approved for stroke/dementia in 40+ countries
- May improve cognitive function post-stroke
- Neuroprotective effects demonstrated
Limited Human Research
Most research on Cerebrolysin has been conducted in animal models. Human clinical trials are limited or absent. Results may not translate directly to humans.
Dosing Protocol
These are general guidelines based on research literature and community protocols. Individual dosing should be determined by a qualified healthcare provider.
Safety & Risks
Reported Side Effects:
Contraindications:
- Epilepsy
- Severe renal impairment
- Pork allergy
Important: This information is for research purposes only. Always consult with a qualified healthcare provider before using any peptide. Never use peptides without proper medical supervision.
Sourcing & Quality
Quality varies significantly between peptide sources. When sourcing Cerebrolysin, consider:
- Third-party testing (HPLC, Mass Spectrometry)
- Certificate of Analysis (CoA) availability
- Purity levels (>98% recommended)
- Beware of LPS (endotoxin) contamination
CalcPep does not sell peptides or recommend specific vendors. Always verify product quality through independent testing.
Aggregated from CalcPep users who have opted in to share anonymous data.
View Full DataTrack Your Protocol
Use CalcPep to calculate doses, log injections, and track your progress.
Get CalcPep